Richa Mittal MD

Richa Mittal MD operates a medical weight management practice in Frisco, Texas, where board-certified expertise in both Internal Medicine and Medical Weight Management converges to address metabolic dysfunction and sustainable weight loss. Dr. Mittal holds dual board certifications that inform her clinical approach to patients struggling with obesity, prediabetes, type 2 diabetes, and metabolic syndrome. The practice serves patients throughout the Dallas-Fort Worth metroplex with both in-person appointments in Frisco and telehealth consultations for Texas residents, making evidence-based metabolic care accessible across the state. Unlike generalist weight loss programs, this clinic integrates comprehensive internal medicine knowledge with specialized training in obesity medicine, allowing Dr. Mittal to address the complex interplay between weight, hormones, insulin resistance, and chronic disease risk.

The clinic's treatment protocols center on GLP-1 receptor agonist medications, specifically Semaglutide and Tirzepatide, prescribed within structured medical weight management programs. Semaglutide, the active compound in medications like Wegovy and Ozempic, works by mimicking the incretin hormone GLP-1 to reduce appetite, slow gastric emptying, and improve glycemic control in patients with type 2 diabetes or obesity. Tirzepatide represents a dual GIP/GLP-1 receptor agonist that has demonstrated superior weight loss outcomes in clinical trials, making it a valuable option for patients who require more aggressive metabolic intervention. Dr. Mittal does not simply prescribe these medications in isolation; each patient undergoes metabolic assessment, laboratory evaluation, and individualized dosing protocols based on their medical history, current medications, and weight loss goals. The practice also incorporates hormone therapy when hormonal imbalances contribute to weight gain or metabolic dysfunction, addressing thyroid disorders, insulin resistance, and sex hormone deficiencies that commonly sabotage weight loss efforts.

Dr. Mittal's clinical methodology emphasizes accountability structures and lifestyle modification alongside pharmacotherapy. Patients receive ongoing monitoring of metabolic markers, medication tolerance, and weight trends, with regular follow-up appointments to adjust treatment protocols as needed. The practice provides nutritional guidance tailored to each patient's metabolic profile, recognizing that optimal macronutrient ratios vary based on insulin sensitivity, activity level, and individual response. Rather than prescribing generic meal plans, Dr. Mittal works with patients to identify sustainable dietary patterns that support medication efficacy while addressing the behavioral and environmental factors that contributed to weight gain. This approach acknowledges that successful weight management requires both biological intervention through medications like Semaglutide and Tirzepatide and practical tools for navigating real-world eating situations, stress management, and long-term habit formation.

Patients beginning treatment at the Frisco clinic can expect an initial comprehensive consultation that includes detailed medical history review, physical examination, laboratory testing to assess metabolic function, and discussion of realistic weight loss goals. Dr. Mittal evaluates contraindications to GLP-1 medications, reviews potential side effects such as nausea and gastrointestinal symptoms, and establishes a titration schedule that minimizes adverse effects while optimizing therapeutic benefit. Follow-up visits occur at regular intervals to monitor progress, adjust medication dosing, address side effects, and provide continued accountability. For patients managing diabetes alongside obesity, the practice coordinates care to ensure that weight loss medications complement existing diabetes management strategies, with careful attention to blood glucose monitoring and adjustment of other diabetes medications as weight loss progresses and insulin sensitivity improves.

The practice's telehealth platform extends access to Dr. Mittal's expertise throughout Texas, allowing patients in Austin, Houston, San Antonio, and rural areas to receive the same level of specialized metabolic care available to Frisco residents. Virtual consultations include the same comprehensive assessment, laboratory review, and treatment planning as in-person visits, with medications shipped directly to patients' homes and ongoing support provided through secure messaging and video follow-ups. This hybrid model addresses a critical gap in obesity medicine access, particularly for patients in areas without board-certified weight management specialists. With a perfect 5.0-star rating across 35 Google reviews, the practice has demonstrated consistent patient satisfaction, with reviewers specifically noting the effectiveness of the metabolic approach, the quality of nutritional guidance, and the accountability structures that support long-term success beyond initial weight loss.